S&S Healthcare Holding Ltd. (TPEX:4198)
Taiwan · Delayed Price · Currency is TWD 41.20
+0.30 (0.73%)
Aug 26, 2026, 12:14 PM CST
S&S Healthcare Holding Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 172.45 | 204.21 | 240.25 | 254.52 | 254.44 | 122.35 | |
Revenue Growth | -22.17% | -15.00% | -5.61% | 0.03% | 107.95% | 20.71% |
Cost of Revenue | 114.47 | 137.1 | 165.24 | 218.87 | 216.05 | 130.29 |
Gross Profit | 57.98 | 67.11 | 75.01 | 35.66 | 38.39 | -7.93 |
Selling, General & Admin | 99.95 | 105.45 | 133.38 | 111.9 | 113.92 | 71.61 |
Research & Development | 8.35 | 8.89 | 10.04 | 15.11 | 21.38 | 24.33 |
Operating Expenses | 109.94 | 113.68 | 142.99 | 128.58 | 148.91 | 95.36 |
Operating Income | -51.95 | -46.57 | -67.98 | -92.92 | -110.52 | -103.29 |
Interest Expense | -0.87 | -1.03 | -2.17 | -5.24 | -2.37 | -1.74 |
Interest & Investment Income | 1.34 | 1.54 | 1.45 | 0.99 | 0.45 | 0.46 |
Earnings From Equity Investments | 5.7 | -3.47 | 0.09 | - | - | - |
Currency Exchange Gain (Loss) | -0.74 | -0.74 | 1.54 | 1.33 | 4.57 | -0.78 |
Other Non Operating Income (Expenses) | 2.61 | 0.69 | 8.66 | 15.06 | 33.43 | 9.99 |
EBT Excluding Unusual Items | -43.92 | -49.58 | -58.41 | -80.79 | -74.44 | -95.34 |
Gain (Loss) on Sale of Investments | 1.13 | 1.13 | - | - | - | - |
Gain (Loss) on Sale of Assets | -0 | -0 | 12.08 | 186.58 | 4.07 | -0.05 |
Asset Writedown | - | - | - | -3.15 | - | - |
Other Unusual Items | - | - | - | 0.21 | - | - |
Pretax Income | -42.79 | -48.45 | -46.33 | 102.86 | -70.37 | -95.39 |
Income Tax Expense | -0.58 | -0.51 | 2.16 | -0.03 | -1.21 | - |
Earnings From Continuing Operations | -42.21 | -47.94 | -48.49 | 102.89 | -69.16 | -95.39 |
Minority Interest in Earnings | 1.74 | 0.65 | 7.22 | 0.72 | 2.27 | - |
Net Income | -40.47 | -47.3 | -41.28 | 103.61 | -66.89 | -95.39 |
Net Income to Common | -40.47 | -47.3 | -41.28 | 103.61 | -66.89 | -95.39 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 24 | 24 | 24 | 23 | 18 | 15 |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 23 | 18 | 15 |
Shares Change | -0.12% | - | 4.56% | 30.09% | 21.08% | 18.96% |
EPS (Basic) | -1.68 | -1.96 | -1.71 | 4.49 | -3.77 | -6.52 |
EPS (Diluted) | -1.68 | -1.96 | -1.71 | 4.49 | -3.77 | -6.52 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -38.81 | -29.12 | -57.74 | -98.7 | -89.07 | -80.04 |
Free Cash Flow Per Share | -1.61 | -1.21 | -2.40 | -4.28 | -5.03 | -5.47 |
Gross Margin | 33.62% | 32.87% | 31.22% | 14.01% | 15.09% | -6.48% |
Operating Margin | -30.13% | -22.80% | -28.30% | -36.51% | -43.44% | -84.42% |
Profit Margin | -23.47% | -23.16% | -17.18% | 40.71% | -26.29% | -77.97% |
Free Cash Flow Margin | -22.50% | -14.26% | -24.03% | -38.78% | -35.01% | -65.42% |
EBITDA | -36.38 | -33.45 | -48.63 | -71.88 | -81.63 | -88.93 |
EBITDA Margin | -21.09% | -16.38% | -20.24% | -28.24% | -32.08% | -72.69% |
D&A For EBITDA | 15.58 | 13.12 | 19.35 | 21.04 | 28.88 | 14.35 |
EBIT | -51.95 | -46.57 | -67.98 | -92.92 | -110.52 | -103.29 |
EBIT Margin | -30.13% | -22.80% | -28.30% | -36.51% | -43.44% | -84.42% |
Advertising Expenses | - | - | - | 3.92 | 4.29 | 1.33 |